Skip to content
People

Michael Bielski

Chief Executive Officer at Spearhead Bio.

Earliest Form D on file: Jun 2026

Filed Jun 23, 2026

Spearhead Bio

Gene insertion tools for crop genome editing

Biotech, Saint Louis MO

Signed as Chief Executive Officer

$1.2M

sold of $1.75M offered

Form D

Network

At Spearhead Bio

3 people